Loading stock data...

Desh Rakshak Aushdhalaya Ltd.

BSE: DESHRAK

BSE
25.65 -1.35 (-5.00%)

Prev Close

27

Open Price

25.65

Volume

1,100

Today Low / High

25.65 / 25.65

52 WK Low / High

25.65 / 95.14

Range

24 - 27

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 25.65, reflecting a change of -1.35 (-5%). The expected target range on the BSE is 24 - 27. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

24 Feb 25.65 0.00%
23 Feb 25.65 0.00%
20 Feb 27.00 0.00%
19 Feb 27.00 0.00%
18 Feb 28.25 0.00%
17 Feb 28.32 0.00%
16 Feb 28.32 0.00%
13 Feb 27.10 -0.70%
12 Feb 28.32 0.00%
11 Feb 28.32 0.00%
10 Feb 30.90 -3.56%
09 Feb 31.00 0.97%
06 Feb 32.00 0.00%
05 Feb 32.00 0.00%
04 Feb 32.00 0.00%
03 Feb 32.00 0.00%
02 Feb 32.00 0.00%
30 Jan 32.00 0.00%
29 Jan 32.00 0.00%
28 Jan 32.00 0.00%

Desh Rakshak Aushdhalaya Ltd. Graph

Desh Rakshak Aushdhalaya Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Desh Rakshak Aushdhalaya Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 25.65, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 25.65 25.91 23.32 - 28.50
26.16 20.93 - 31.40
26.42 18.49 - 34.35
Bearish Scenario 25.65 25.39 22.85 - 27.93
25.14 20.11 - 30.16
24.88 17.42 - 32.34

Overview of Desh Rakshak Aushdhalaya Ltd.

ISIN

INE971E01016

Industry

Medical - Pharmaceuticals

Vol.Avg

206

Market Cap

113,713,529

Last Dividend

0

Official Website

Visit Website

IPO Date

1998-12-30

DCF Diff

55.81

DCF

-28

Financial Ratios Every Investor Needs

Stock Rating Details for DESHRAK

Metric Value Recommendation
Overall Rating B- Sell
DCF Score 1 Strong Sell
ROE Score 3 Neutral
ROA Score 3 Neutral
Debt-to-Equity (DE) Score 3 Neutral
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 3 Neutral

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 6.27 Cr 2.57 Cr 3.70 Cr 0.5905 0.00 Cr 0.00 Cr 0.83 Cr 0.48 Cr 1.07 1.28 Cr 0.0760
2024-03-31 6.01 Cr 2.52 Cr 3.49 Cr 0.5802 0.00 Cr 0.11 Cr 0.51 Cr 0.43 Cr 0.96 1.30 Cr 0.0712
2023-03-31 6.18 Cr 2.75 Cr 3.43 Cr 0.5550 0.00 Cr 0.16 Cr 0.48 Cr 0.41 Cr 0.93 1.33 Cr 0.0656
2022-03-31 6.19 Cr 2.64 Cr 3.55 Cr 0.5734 0.00 Cr 0.10 Cr 0.81 Cr 0.48 Cr 1.08 1.18 Cr 0.0778
2021-03-31 6.60 Cr 3.49 Cr 3.10 Cr 0.4704 0.00 Cr 0.12 Cr 0.73 Cr 0.42 Cr 0.95 0.95 Cr 0.0637

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.07 Cr 17.98 Cr 8.02 Cr 9.9552 Cr 3.04 Cr 2.97 Cr 0.19 Cr 9.70 Cr 0.00 Cr 0.00 Cr 0.05 Cr 4.9389 Cr
2024-03-31 0.14 Cr 16.32 Cr 6.84 Cr 9.4786 Cr 2.83 Cr 2.70 Cr 0.30 Cr 10.05 Cr 0.00 Cr 0.00 Cr 0.05 Cr 4.0077 Cr
2023-03-31 0.05 Cr 15.74 Cr 6.61 Cr 9.1346 Cr 4.18 Cr 4.13 Cr 0.81 Cr 10.44 Cr 0.00 Cr 0.00 Cr 0.05 Cr 2.4268 Cr
2022-03-31 0.23 Cr 16.12 Cr 6.84 Cr 9.2851 Cr 4.33 Cr 4.10 Cr 0.85 Cr 10.19 Cr 0.00 Cr 0.00 Cr 0.05 Cr 2.5134 Cr
2021-03-31 0.59 Cr 14.57 Cr 5.77 Cr 8.8018 Cr 2.98 Cr 2.38 Cr 0.69 Cr 8.86 Cr 0.00 Cr 0.00 Cr 0.05 Cr 2.7928 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -0.2977 Cr -0.0196 Cr 0.2478 Cr -0.8692 Cr -0.0694 Cr 0.0676 Cr -0.5716 Cr 0.5647 Cr 0.2478 Cr 0.0000 Cr 0.1060 Cr
2024-03-31 1.5166 Cr -0.0871 Cr -1.3441 Cr 1.4665 Cr 0.0854 Cr 0.1371 Cr -0.0501 Cr 0.5066 Cr -1.3441 Cr 0.0000 Cr 0.5068 Cr
2023-03-31 0.4502 Cr -0.7754 Cr 0.1479 Cr -0.3523 Cr -0.1773 Cr 0.0517 Cr -0.8025 Cr 0.4806 Cr 0.1479 Cr 0.0000 Cr -0.0400 Cr
2022-03-31 0.2322 Cr -1.9457 Cr 1.3494 Cr -1.5067 Cr -0.3641 Cr 0.2290 Cr -1.7389 Cr 0.5703 Cr 1.3494 Cr 0.0000 Cr -0.1570 Cr
2021-03-31 0.8369 Cr -1.2632 Cr 0.7997 Cr -0.5395 Cr 0.3734 Cr 0.5930 Cr -1.3764 Cr 0.5469 Cr 0.7997 Cr 0.0000 Cr 0.0993 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 0.95 Cr 0.16 Cr 0.80 Cr 0.8343 0.16 Cr 0.08 Cr 0.15 0.26 Cr 0.0872
2025-06-30 1.30 Cr 0.50 Cr 0.80 Cr 0.6128 0.15 Cr 0.10 Cr 0.22 0.25 Cr 0.0738
2025-03-31 2.12 Cr 0.92 Cr 1.20 Cr 0.5643 0.26 Cr 0.12 Cr 0.27 0.36 Cr 0.0560
2024-12-31 1.88 Cr 0.85 Cr 1.03 Cr 0.5464 0.76 Cr 0.12 Cr 0.27 0.31 Cr 0.0638
2024-09-30 1.19 Cr 0.39 Cr 0.80 Cr 0.6761 0.58 Cr 0.15 Cr 0.33 0.33 Cr 0.1225

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.41 Cr 0.31 Cr 0.72 Cr 8.63 Cr 0.24 Cr 9.59 Cr 9.83 Cr 19.46 Cr 6.56 Cr
2025-06-30 0.00 Cr 0.00 Cr 0.07 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -9.96 Cr
2025-03-31 0.07 Cr 0.00 Cr 0.07 Cr 7.71 Cr 0.19 Cr 7.97 Cr 9.70 Cr 17.98 Cr 8.02 Cr
2024-12-31 0.12 Cr 0.00 Cr 0.12 Cr 0.00 Cr 0.00 Cr 0.12 Cr 0.00 Cr 0.00 Cr -9.69 Cr
2024-09-30 0.12 Cr 0.00 Cr 0.12 Cr 5.80 Cr 0.14 Cr 6.76 Cr 9.85 Cr 16.66 Cr 6.97 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.10 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 0.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.12 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.15 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹854.80 ₹102,578,890,079.00 ₹242,213.00

Key Executives

Chief Financial Officer
Amit Kumar Singh

Gender: male

Year Born:

Whole Time Director
Arihant Kumar Jain

Gender: male

Year Born: 1989

Whole Time Director
Monika Jain

Gender: female

Year Born: 1969

Company Secretary & Compliance Officer
Sohini Bansal

Gender: female

Year Born:

Chairman & MD
Tosh Kumar Jain

Gender: male

Year Born: 1964

FAQs about Desh Rakshak Aushdhalaya Ltd.

Who is the CEO of the company?

The CEO is Tosh Kumar Jain.

What is the current market price of the stock?

The current price is ₹25.65.

What is the 52-week price range?

The range is ₹25.65-95.14.

What is the market capitalization of the company?

The market capitalization is ₹11.37 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 34.05.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Desh Rakshak Aushdhalaya Ltd. (ISIN: INE971E01016) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹11.37 crores and an average daily volume of 206 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.